HUP0103203A3 - Azaadamantane derivatives and pharmaceutical compositions thereof - Google Patents

Azaadamantane derivatives and pharmaceutical compositions thereof

Info

Publication number
HUP0103203A3
HUP0103203A3 HU0103203A HUP0103203A HUP0103203A3 HU P0103203 A3 HUP0103203 A3 HU P0103203A3 HU 0103203 A HU0103203 A HU 0103203A HU P0103203 A HUP0103203 A HU P0103203A HU P0103203 A3 HUP0103203 A3 HU P0103203A3
Authority
HU
Hungary
Prior art keywords
pharmaceutical compositions
azaadamantane derivatives
azaadamantane
derivatives
pharmaceutical
Prior art date
Application number
HU0103203A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of HUP0103203A2 publication Critical patent/HUP0103203A2/hu
Publication of HUP0103203A3 publication Critical patent/HUP0103203A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU0103203A 1998-08-18 1999-08-16 Azaadamantane derivatives and pharmaceutical compositions thereof HUP0103203A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9697798P 1998-08-18 1998-08-18
PCT/US1999/018570 WO2000011001A1 (en) 1998-08-18 1999-08-16 Muscarinic agonists and antagonists

Publications (2)

Publication Number Publication Date
HUP0103203A2 HUP0103203A2 (hu) 2002-01-28
HUP0103203A3 true HUP0103203A3 (en) 2002-10-28

Family

ID=22260061

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0103203A HUP0103203A3 (en) 1998-08-18 1999-08-16 Azaadamantane derivatives and pharmaceutical compositions thereof

Country Status (30)

Country Link
US (5) US6093724A (zh)
EP (1) EP1112272B1 (zh)
JP (1) JP2002523416A (zh)
KR (1) KR20010072784A (zh)
CN (1) CN1312812A (zh)
AR (1) AR020199A1 (zh)
AT (1) ATE227724T1 (zh)
AU (1) AU750566B2 (zh)
BG (1) BG105256A (zh)
BR (1) BR9913072A (zh)
CA (1) CA2340946A1 (zh)
CO (1) CO5130018A1 (zh)
DE (1) DE69903961T2 (zh)
EE (1) EE200100096A (zh)
ES (1) ES2191455T3 (zh)
HK (1) HK1038918A1 (zh)
HU (1) HUP0103203A3 (zh)
ID (1) ID27544A (zh)
IL (1) IL141050A0 (zh)
IS (1) IS5827A (zh)
NO (1) NO20010804L (zh)
NZ (1) NZ509762A (zh)
PE (1) PE20000988A1 (zh)
PL (1) PL346247A1 (zh)
RU (1) RU2219179C2 (zh)
SK (1) SK1892001A3 (zh)
TR (1) TR200100462T2 (zh)
WO (1) WO2000011001A1 (zh)
YU (1) YU13301A (zh)
ZA (1) ZA200100978B (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200300392A1 (ru) * 2000-10-19 2003-10-30 Пфайзер Продактс Инк. Производные пиперазина с мостиковой связью
GB0117950D0 (en) * 2001-02-16 2001-09-19 Aventis Pharma Inc Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands
WO2002094827A1 (en) * 2001-05-23 2002-11-28 Neurosearch A/S Fused tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US20030064979A1 (en) * 2001-06-29 2003-04-03 Hansen Thomas Kruse Method of inhibiting PTP 1B and /or T-cell PTP and/or other PTPases with an Asp residue at position 48
US6828328B1 (en) * 2002-03-01 2004-12-07 Ucb S.A. Analgesic combination of muscarinic agonists
US7897766B2 (en) * 2005-09-23 2011-03-01 Abbott Laboratories Amino-aza-adamantane derivatives and methods of use
US8314119B2 (en) * 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
US8076350B2 (en) 2006-12-22 2011-12-13 Abbott Laboratories Spirocyclic azaadamantane derivatives and methods of use
EP2497771A1 (en) * 2007-03-23 2012-09-12 Abbott Laboratories 4 -substituted azaadamantane derivatives and methods of use thereof
ES2378116T3 (es) 2007-03-23 2012-04-09 Abbott Laboratories Derivados acetamida y carboxamida de azaadamantano y métodos de uso de los mismos
MX2011014019A (es) * 2009-06-19 2012-02-22 Abbott Lab Derivados de diazahomoadamantano y sus metodos de uso.
ES2742728T3 (es) 2009-07-22 2020-02-17 PureTech Health LLC Composiciones para el tratamiento de trastornos mejorados por la activación del receptor muscarínico
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
WO2011133920A1 (en) 2010-04-23 2011-10-27 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
NZ707955A (en) * 2010-09-23 2016-03-31 Abbvie Bahamas Ltd Monohydrate of an azaadamantane derivative
US8759380B2 (en) 2011-04-22 2014-06-24 Cytokinetics, Inc. Certain heterocycles, compositions thereof, and methods for their use
WO2019126559A1 (en) * 2017-12-20 2019-06-27 Vanderbilt University Antagonists of the muscarinic acetylcholine receptor m4
AU2019346626B2 (en) 2018-09-28 2022-06-02 Karuna Therapeutics, Inc. Compositions and methods for treating disorders ameliorated by muscarinic receptor activation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739074A (en) * 1986-01-22 1988-04-19 Pennwalt Corporation Adamantane spiro-pyrrolidine derivatives
IE63906B1 (en) * 1987-11-13 1995-06-14 Novo Nordisk As Azabicyclic compounds and their preparation and use
US5527813A (en) * 1990-08-21 1996-06-18 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
JPH06502616A (ja) * 1990-12-21 1994-03-24 メルク　シヤープ　エンド　ドーム　リミテツド 治療用化合物
US5955470A (en) * 1991-06-11 1999-09-21 Merrell Pharmaceuticals, Inc. Derivatives of amide analogs of certain methano bridged quinolizines
US5641791A (en) * 1991-08-13 1997-06-24 Novo Nordisk A.S Heterocyclic compounds and their preparation and use
ATE224392T1 (de) * 1995-11-02 2002-10-15 Neurosearch As Kondensierte tropanderivate als neurotransmitter- reuptake-inhibitoren
US5914338A (en) * 1996-04-02 1999-06-22 Novo Nordisk Heterocyclic compounds and their preparation and use
US5986100A (en) * 1998-04-02 1999-11-16 Crooks; Peter Anthony Pharmaceutical compositions and methods for use
US5952339A (en) * 1998-04-02 1999-09-14 Bencherif; Merouane Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release
US6057446A (en) * 1998-04-02 2000-05-02 Crooks; Peter Anthony Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds

Also Published As

Publication number Publication date
KR20010072784A (ko) 2001-07-31
CO5130018A1 (es) 2002-02-27
EP1112272A1 (en) 2001-07-04
AU5775899A (en) 2000-03-14
US6423842B1 (en) 2002-07-23
ES2191455T3 (es) 2003-09-01
US6323194B1 (en) 2001-11-27
ATE227724T1 (de) 2002-11-15
US6093724A (en) 2000-07-25
PE20000988A1 (es) 2000-09-30
JP2002523416A (ja) 2002-07-30
AR020199A1 (es) 2002-05-02
NZ509762A (en) 2002-12-20
IL141050A0 (en) 2002-02-10
IS5827A (is) 2001-01-26
US6251916B1 (en) 2001-06-26
AU750566B2 (en) 2002-07-25
HK1038918A1 (zh) 2002-04-04
DE69903961D1 (de) 2002-12-19
HUP0103203A2 (hu) 2002-01-28
YU13301A (sh) 2005-06-10
CN1312812A (zh) 2001-09-12
PL346247A1 (en) 2002-01-28
WO2000011001A1 (en) 2000-03-02
DE69903961T2 (de) 2003-07-03
US6555550B1 (en) 2003-04-29
EE200100096A (et) 2002-06-17
NO20010804D0 (no) 2001-02-16
US20020045617A1 (en) 2002-04-18
CA2340946A1 (en) 2000-03-02
BG105256A (en) 2001-11-30
ID27544A (id) 2001-04-12
RU2219179C2 (ru) 2003-12-20
ZA200100978B (en) 2002-02-05
TR200100462T2 (tr) 2001-09-21
BR9913072A (pt) 2001-05-15
NO20010804L (no) 2001-04-11
SK1892001A3 (en) 2001-11-06
EP1112272B1 (en) 2002-11-13

Similar Documents

Publication Publication Date Title
HUP0103406A3 (en) 1h-imidazopyridine derivatives and pharmaceutical compositions thereof
HUP0102990A3 (en) Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof
IL138899A0 (en) Amidene derivatives and pharmaceutical compositions containing the same
IL140862A (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the same
IL138573A0 (en) Amide derivatives and pharmaceutical compositions containing the same
HUP0400887A3 (en) Glycopeptide derivatives and pharmaceutical compositions containing the same
IL143920A0 (en) 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same
IL141456A0 (en) Rhodanine derivatives and pharmaceutical compositions containing the same
HUP0100178A3 (en) Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof
IL152451A0 (en) 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same
HUP0301178A3 (en) Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same
IL142665A0 (en) Acyl dipeptidyl derivatives and pharmaceutical compositions containing the same
IL153123A0 (en) N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same
HUP0101381A3 (en) Benzofurylpyrone derivatives and pharmaceutical compositions containing them
HUP9900424A2 (hu) Tiazolil-benzfurán-származékok és a vegyületeket tartalmazó gyógyászati készítmények
HUP0103203A3 (en) Azaadamantane derivatives and pharmaceutical compositions thereof
IL147214A0 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
HUP0105075A3 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives, their use and pharmaceutical compositions containing them
HUP0100680A3 (en) Indole derivatives and medicinal compositions containing the same
HUP0100085A3 (en) Biphenylamidine derivatives and pharmaceutical compositions containing them
HUP0002331A3 (en) 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof
HUP0003398A2 (en) Novel triptolide derivatives and pharmaceutical compositions thereof
HUP0104852A3 (en) Oktahydro-pyrido-pyrazine derivatives and pharmaceutical compositions containing the same and their use
HUP0101733A3 (en) Pharmaceutical compositions containing sulfonyl-dipeptides and their use
HUP0104549A3 (en) Imidazo-pyridine sulfonamide derivatives and pharmaceutical compositions thereof